In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals. Seth and Mike explored the two programs Tonix are currently developing in pain and psychiatry, areas where many larger companies have turned their back […]

Dr. Paul Wotton, CEO of Obsidian Therapeutics, discusses Obsidian’s platform, cytoDRiVE™, that regulates protein levels in cell and gene therapies, creating an “operating system” for living drugs. This means that now, and for the first time, physicians will be able to control genetically-engineered cells’ biologic activity to increase efficacy and reduce toxicity, using easily accessed generics […]

A Massachusetts patient with COVID-19 and pneumonia responded positively to a laser therapy meant to promote healing, according to a case study published in the American Journal of Case Reports. The article details a COVID-19 case involving a 57-year-old man admitted to the intensive care unit for respiratory distress. The man had daily, 28-minute sessions of photobiomodulation therapy […]